Clinical pharmacokinetics and drug–drug interactions of tyrosine-kinase inhibitors in chronic myeloid leukemia: A clinical perspective
Article in Critical Reviews in Oncology/Hematology (February 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Atypical N‑Alkyl to N‑Noralkoxy Switch in a Dual cSRC/BCR-ABL1 Kinase Inhibitor Improves Drug Efflux and hERG Affinity
Article in ACS Medicinal Chemistry Letters (December 2023)
Transporter-Mediated Cellular Distribution of Tyrosine Kinase Inhibitors as a Potential Resistance Mechanism in Chronic Myeloid Leukemia
Article in Pharmaceutics (October 2023)